Carregant...
Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide
BACKGROUND: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts amenorrhea or oligomenorrhea 6 months after cyclophosphamide CTX in women with breast cancer. METHODS: 52 eumenorrheic patients with breast cancer were enrolled. FSH, anti-Müllerian hormone (AMH), antral...
Guardat en:
Publicat a: | J Ovarian Res |
---|---|
Autors principals: | , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
BioMed Central
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4678664/ https://ncbi.nlm.nih.gov/pubmed/26667243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-015-0209-4 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|